Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
On-demand video webcast now available here PRINCETON, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the ...
TMCnet5d
Abpro Statement on the Departure of Former CEO Ian Chan
WOBURN, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing next-generation antibody therapies for severe and ...
The Manila Times5d
Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
BERKELEY, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial ...
Cancer Research20d
Abstract A017: Cysteine-Engineered CAR-T Cells to Counter Antigen Escape in B Cell Lymphoma
Therefore, we generated bifunctional CAR-T cells by cysteine-engineering the clinically approved anti-CD19 single-chain variable fragment (scFv) CAR to overcome CD19 antigen escape. Our data ...